Revised SPC: Mezavant XL (mesalazine) 1200mg, gastro-resistant, prolonged release tablets

SPC revised to include new paediatric indication; for induction and maintenance of clinical and endoscopic remission in children and adolescents (weighing more than 50 kg and age 10 years or older) with mild to moderate, active ulcerative colitis.

Source:

electronic Medicines compendium